Dr. Prashanth R. Vennalaganti, MD

Dr. Vennalaganti practices at Tallahassee Endoscopy Center in Tallahassee, Florida.

Dr. Vennalaganti's NPI, 1205032612, was assigned on June 22, 2007. Dr. Vennalaganti graduated from Yerevan State Medical University in 2000. Dr. Vennalaganti holds Florida license ME145021.

Dr. Vennalaganti's primary practice is Tallahassee Endoscopy Center, at 2400 Miccosukee Rd, Tallahassee, FL 32308. The practice phone is (904) 942-4706.

Dr. Vennalaganti's primary practice is Tallahassee Endoscopy Center in Tallahassee, Florida. Dr. Vennalaganti is also affiliated with Tallahassee Memorial Hospital. The medical group on file is Digestive Disease Clinic. Dmand AI also links Dr. Vennalaganti to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vennalaganti practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Vennalaganti's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Vennalaganti is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Vennalaganti's licenses on file in 2 states: Florida and Iowa.

Dmand AI lists acid reflux, acute gastroduodenitis, colonoscopy, gastroenteritis, gastrointestinal bleeding, intestinal diverticulosis, irritable bowel syndrome (IBS) and upper GI endoscopy among the conditions Dr. Vennalaganti treats.

CMS data shows 466 Medicare services from Dr. Vennalaganti across 11 procedure codes in 2024, for 234 Medicare patients. Medicare paid $46,547 for them.

CMS counts 234 Medicare patients who saw Dr. Vennalaganti in 2024. The largest group is 65 to 74, with 95 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Vennalaganti's median patient age at 54, with 55% women.

In 2024, Dr. Vennalaganti wrote 448 Medicare Part D claims for 240 patients. 87% of them were for generic drugs. CMS names the drug for 334 of them, across 5 drugs with 11 or more claims each, at $7,158 in total drug cost. In 2023, CMS named 293 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Vennalaganti for performance year 2024, reported as part of a group. Dr. Vennalaganti accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 31 papers to Dr. Vennalaganti, published from 2014 to 2022. 2015 was the busiest year, with 6. The most frequent topics are Barrett Esophagus, Adenoma and Esophageal Neoplasms. Dr. Vennalaganti has published most often in Gastroenterology. Dr. Vennalaganti's most frequent co-authors are Prateek Sharma, MD, Madhav V. Desai, MD, MPH and Srinivas Gaddam, MD.

CMS Open Payments shows 58 general payments to Dr. Vennalaganti from 21 drug and device companies from 2016 to 2025. Grants make up the largest share, 60% of the total. Cook Medical LLC paid the most, $5,208.

Dr. Vennalaganti graduated from Yerevan State Medical University in 2000.

Dr. Vennalaganti is in network with 17 carriers, including Aetna, Excellus BlueCross BlueShield and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.